HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-AUG-11 3VHE TITLE CRYSTAL STRUCTURE OF HUMAN VEGFR2 KINASE DOMAIN WITH A NOVEL TITLE 2 PYRROLOPYRIMIDINE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 811-1169); COMPND 5 SYNONYM: VEGFR-2, FETAL LIVER KINASE 1, FLK-1, KINASE INSERT DOMAIN COMPND 6 RECEPTOR, PROTEIN-TYROSINE KINASE RECEPTOR FLK-1; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FLK1, KDR; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE DOMAIN, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.OGURO,N.MIYAMOTO,K.OKADA,T.TAKAGI,H.IWATA,Y.AWAZU,H.MIKI,A.HORI, AUTHOR 2 K.KAMIYAMA,S.IMANURA REVDAT 2 20-MAR-24 3VHE 1 REMARK REVDAT 1 02-NOV-11 3VHE 0 JRNL AUTH Y.OGURO,N.MIYAMOTO,K.OKADA,T.TAKAGI,H.IWATA,Y.AWAZU,H.MIKI, JRNL AUTH 2 A.HORI,K.KAMIYAMA,S.IMAMURA JRNL TITL DESIGN, SYNTHESIS, AND EVALUATION OF JRNL TITL 2 5-METHYL-4-PHENOXY-5H-PYRROLO[3,2-D]PYRIMIDINE DERIVATIVES: JRNL TITL 3 NOVEL VEGFR2 KINASE INHIBITORS BINDING TO INACTIVE KINASE JRNL TITL 4 CONFORMATION. JRNL REF BIOORG.MED.CHEM. V. 18 7260 2010 JRNL REFN ISSN 0968-0896 JRNL PMID 20833055 JRNL DOI 10.1016/J.BMC.2010.08.017 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1354161.360 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 54838 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2738 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7648 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE : 0.2640 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 405 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2430 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 467 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.64000 REMARK 3 B22 (A**2) : 0.25000 REMARK 3 B33 (A**2) : 1.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.74000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.17 REMARK 3 ESD FROM SIGMAA (A) : 0.10 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.10 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.710 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.110 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.740 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.040 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.020 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 45.66 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : 1234567.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : 1234567.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3VHE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1000095046. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56322 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.3M TRI-SODIUM CITRATE, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 67.17000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.13500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 67.17000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.13500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 940 REMARK 465 LYS A 941 REMARK 465 GLY A 942 REMARK 465 ALA A 943 REMARK 465 ARG A 944 REMARK 465 PHE A 945 REMARK 465 ARG A 946 REMARK 465 GLN A 947 REMARK 465 GLY A 948 REMARK 465 LYS A 949 REMARK 465 ASP A 950 REMARK 465 TYR A 951 REMARK 465 VAL A 952 REMARK 465 GLY A 953 REMARK 465 ALA A 954 REMARK 465 ILE A 955 REMARK 465 PRO A 956 REMARK 465 VAL A 957 REMARK 465 ASP A 958 REMARK 465 LEU A 959 REMARK 465 LYS A 960 REMARK 465 ARG A 961 REMARK 465 ARG A 962 REMARK 465 LEU A 963 REMARK 465 ASP A 964 REMARK 465 SER A 965 REMARK 465 ILE A 966 REMARK 465 THR A 967 REMARK 465 SER A 968 REMARK 465 SER A 969 REMARK 465 GLN A 970 REMARK 465 SER A 971 REMARK 465 SER A 972 REMARK 465 ALA A 973 REMARK 465 SER A 974 REMARK 465 SER A 975 REMARK 465 GLY A 976 REMARK 465 PHE A 977 REMARK 465 VAL A 978 REMARK 465 GLU A 979 REMARK 465 GLU A 980 REMARK 465 LYS A 981 REMARK 465 SER A 982 REMARK 465 LEU A 983 REMARK 465 SER A 984 REMARK 465 ASP A 985 REMARK 465 VAL A 986 REMARK 465 GLU A 987 REMARK 465 GLU A 988 REMARK 465 GLU A 989 REMARK 465 GLU A 990 REMARK 465 ALA A 991 REMARK 465 PRO A 992 REMARK 465 GLU A 993 REMARK 465 GLY A 1063 REMARK 465 ASP A 1064 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 815 CG CD OE1 OE2 REMARK 470 ASP A 994 CG OD1 OD2 REMARK 470 LEU A 995 CG CD1 CD2 REMARK 470 LYS A1055 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1027 -6.09 79.34 REMARK 500 ASP A1028 45.53 -152.31 REMARK 500 SER A1037 -169.37 -105.45 REMARK 500 ASP A1112 -163.31 -127.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 42Q A 1170 DBREF 3VHE A 811 1169 UNP P35968 VGFR2_HUMAN 811 1169 SEQRES 1 A 359 LEU PRO LEU ASP GLU HIS CYS GLU ARG LEU PRO TYR ASP SEQRES 2 A 359 ALA SER LYS TRP GLU PHE PRO ARG ASP ARG LEU LYS LEU SEQRES 3 A 359 GLY LYS PRO LEU GLY ARG GLY ALA PHE GLY GLN VAL ILE SEQRES 4 A 359 GLU ALA ASP ALA PHE GLY ILE ASP LYS THR ALA THR CYS SEQRES 5 A 359 ARG THR VAL ALA VAL LYS MET LEU LYS GLU GLY ALA THR SEQRES 6 A 359 HIS SER GLU HIS ARG ALA LEU MET SER GLU LEU LYS ILE SEQRES 7 A 359 LEU ILE HIS ILE GLY HIS HIS LEU ASN VAL VAL ASN LEU SEQRES 8 A 359 LEU GLY ALA CYS THR LYS PRO GLY GLY PRO LEU MET VAL SEQRES 9 A 359 ILE VAL GLU PHE CYS LYS PHE GLY ASN LEU SER THR TYR SEQRES 10 A 359 LEU ARG SER LYS ARG ASN GLU PHE VAL PRO TYR LYS THR SEQRES 11 A 359 LYS GLY ALA ARG PHE ARG GLN GLY LYS ASP TYR VAL GLY SEQRES 12 A 359 ALA ILE PRO VAL ASP LEU LYS ARG ARG LEU ASP SER ILE SEQRES 13 A 359 THR SER SER GLN SER SER ALA SER SER GLY PHE VAL GLU SEQRES 14 A 359 GLU LYS SER LEU SER ASP VAL GLU GLU GLU GLU ALA PRO SEQRES 15 A 359 GLU ASP LEU TYR LYS ASP PHE LEU THR LEU GLU HIS LEU SEQRES 16 A 359 ILE CYS TYR SER PHE GLN VAL ALA LYS GLY MET GLU PHE SEQRES 17 A 359 LEU ALA SER ARG LYS CYS ILE HIS ARG ASP LEU ALA ALA SEQRES 18 A 359 ARG ASN ILE LEU LEU SER GLU LYS ASN VAL VAL LYS ILE SEQRES 19 A 359 CYS ASP PHE GLY LEU ALA ARG ASP ILE TYR LYS ASP PRO SEQRES 20 A 359 ASP TYR VAL ARG LYS GLY ASP ALA ARG LEU PRO LEU LYS SEQRES 21 A 359 TRP MET ALA PRO GLU THR ILE PHE ASP ARG VAL TYR THR SEQRES 22 A 359 ILE GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP SEQRES 23 A 359 GLU ILE PHE SER LEU GLY ALA SER PRO TYR PRO GLY VAL SEQRES 24 A 359 LYS ILE ASP GLU GLU PHE CYS ARG ARG LEU LYS GLU GLY SEQRES 25 A 359 THR ARG MET ARG ALA PRO ASP TYR THR THR PRO GLU MET SEQRES 26 A 359 TYR GLN THR MET LEU ASP CYS TRP HIS GLY GLU PRO SER SEQRES 27 A 359 GLN ARG PRO THR PHE SER GLU LEU VAL GLU HIS LEU GLY SEQRES 28 A 359 ASN LEU LEU GLN ALA ASN ALA GLN HET 42Q A1170 32 HETNAM 42Q 1-{2-FLUORO-4-[(5-METHYL-5H-PYRROLO[3,2-D]PYRIMIDIN-4- HETNAM 2 42Q YL)OXY]PHENYL}-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA FORMUL 2 42Q C21 H15 F4 N5 O2 FORMUL 3 HOH *467(H2 O) HELIX 1 1 HIS A 816 LEU A 820 5 5 HELIX 2 2 ASP A 823 GLU A 828 1 6 HELIX 3 3 PRO A 830 ASP A 832 5 3 HELIX 4 4 THR A 875 GLY A 893 1 19 HELIX 5 5 LEU A 924 SER A 930 1 7 HELIX 6 6 THR A 1001 ARG A 1022 1 22 HELIX 7 7 ALA A 1030 ARG A 1032 5 3 HELIX 8 8 GLU A 1038 ASN A 1040 5 3 HELIX 9 9 PHE A 1047 ARG A 1051 5 5 HELIX 10 10 PRO A 1068 MET A 1072 5 5 HELIX 11 11 ALA A 1073 ARG A 1080 1 8 HELIX 12 12 THR A 1083 PHE A 1099 1 17 HELIX 13 13 ASP A 1112 GLY A 1122 1 11 HELIX 14 14 THR A 1132 TRP A 1143 1 12 HELIX 15 15 GLU A 1146 ARG A 1150 5 5 HELIX 16 16 THR A 1152 ALA A 1168 1 17 SHEET 1 A 5 LEU A 834 ARG A 842 0 SHEET 2 A 5 GLY A 846 PHE A 854 -1 O VAL A 848 N LEU A 840 SHEET 3 A 5 CYS A 862 LEU A 870 -1 O VAL A 867 N ILE A 849 SHEET 4 A 5 MET A 913 GLU A 917 -1 O VAL A 914 N LYS A 868 SHEET 5 A 5 LEU A 901 CYS A 905 -1 N LEU A 902 O ILE A 915 SHEET 1 B 3 GLY A 922 ASN A 923 0 SHEET 2 B 3 ILE A1034 LEU A1036 -1 O LEU A1036 N GLY A 922 SHEET 3 B 3 VAL A1042 ILE A1044 -1 O LYS A1043 N LEU A1035 SITE 1 AC1 16 VAL A 848 ALA A 866 LYS A 868 GLU A 885 SITE 2 AC1 16 VAL A 898 VAL A 899 VAL A 916 GLU A 917 SITE 3 AC1 16 CYS A 919 LEU A1019 HIS A1026 LEU A1035 SITE 4 AC1 16 ILE A1044 CYS A1045 ASP A1046 PHE A1047 CRYST1 134.340 56.270 52.070 90.00 95.24 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007444 0.000000 0.000683 0.00000 SCALE2 0.000000 0.017771 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019286 0.00000